Table 2.
Study variables for IFG, HTN, and HLD accounting for severity
| Risk factor | Description | Count |
|---|---|---|
| IFG | ||
| ifg.no | FPG ≤100 | 35,110 |
| ifg.pre1 | 100 < FPG ≤110 | 6797 |
| ifg.pre2 | 110 < FPG ≤125 | 1602 |
| HTN | ||
| htn.no | No indication of HTN | 29,603 |
| htn.untx | No drug is needed, and only one blood pressure result is elevated | 5355 |
| htn.tx | Treatment needed | 8551 |
| HLD | ||
| hld.no | No indication of HLD | 12,092 |
| hld.untx | No therapeutic need, but some indication of hyperlipidemia exists (laboratory or diagnosis) | 25,439 |
| hld.tx | Treatment needed | 5978 |
| Obesity | ||
| obese.no | BMI <25 | 13,061 |
| obese.overweight | 25 ≤ BMI <30 | 10,642 |
| obese.obese | diagnosis or BMI ≥30 | 12,188 |
BMI, body mass index; FPG, fasting plasma glucose; HLD, hyperlipidemia; IFG, impaired fasting glucose.